Pfizer invests in French gene therapy co.

Pfizer announced it has acquired a 15 percent stake in Vivet Therapeutics, with an exclusive option to fully acquire the privately-held French gene therapy company.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news